Skip to content

S 5043 · 119th Congress

A bill to direct the Food and Drug Administration to prevent the importation of counterfeit, unapproved, misbranded, or adulterated drugs from the People's Republic of China or other foreign countries, to establish enhanced safeguards for imported drug products, and for other purposes.

Introduced Jul 21, 2026Last action Jul 21, 2026Congress.gov →

Latest action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsor

Ted BuddRepublican · NCProfile →